poisar

Stocks · News reference

Baird Maintains Outperform on Veeva Systems, Raises Price Target to $300

Benzinga Newsdesk

Baird analyst Joe Vruwink maintains Veeva Systems (NYSE:VEEV) with a Outperform and raises the price target from $260 to $300.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

VEEV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks.Com

    VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast

    Veeva Systems raised its fiscal 2027 revenue guidance to $3.682-$3.687B (implying ~15% growth), driven by strong Vault CRM adoption with commitments from 12 of top 20 biopharma firms and 180+ live customers. The company's Falcon AI product has five early adopters, though execution remains a key near-term priority. While profitability is maintained with a 44% operating margin, newer initiatives like CRM migrations and AI monetization still require sustained execution.

    VEEVCRMIQV
  2. Market Updates

    The Market Just Told You Which Layer Of AI Biology It Is Paying For

    Recent earnings in life sciences technology reveal that the market is rewarding companies with proprietary data and systems of record over those selling software or AI models alone. Veeva Systems beat expectations with strong AI product adoption, while Certara missed on modest software growth and Recursion Pharmaceuticals fell short on revenue expectations. MindWalk Holdings, which owns curated biological data infrastructure, is positioned to benefit from this trend with its HYFT Technology and newly launched ReefIQ platform, though it remains unprofitable with modest recurring revenue.

    VEEVCERTRXRXILMNHYFT
  3. Josh Kohn-Lindquist

    Veeva's Exiting President Sold $2.8 Million in Stock: What Investors Need to Know

    Thomas D. Schwenger, President and Chief Customer Officer of Veeva Systems, sold 10,000 shares worth $2.8 million on August 27, 2026, under a pre-arranged Rule 10b5-1 trading plan. The sale should not alarm investors as Schwenger is departing the company on October 2, 2026, and the transaction was pre-planned for liquidity purposes rather than a market timing bet. Veeva has rebounded strongly with a 55% gain over six months following successful earnings beats and a successful transition to its own Vault CRM platform.

    VEEVCRM
  4. Zacks.Com

    Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now?

    RSPH, an equal-weight healthcare ETF launched in 2006, has gained 17.92% year-to-date and 29.15% over the past year as of August 31, 2026. With $826.52 million in assets and a 0.40% expense ratio, it offers diversified exposure to 63 healthcare holdings. However, cheaper alternatives like VHT (0.09% expense ratio) and XLV (0.08% expense ratio) may be more suitable for cost-conscious investors seeking lower-risk options.

    RSPHVHTXLVCRLVEEV